| Reference |
|---|
Li Y, Zhu N, Ahmed M, Urbina J, Huang T, Wong P. Three-dimensional computer vision for exploring heterogeneity in collective Cancer Invasion. Sci Rep. 2024;14:23560 pubmed publisher |
Fu Z, Chen Z, Ye J, Ji J, Ni W, Lin W, et al. Identifying PLAUR as a Pivotal Gene of Tumor Microenvironment and Regulating Mesenchymal Phenotype of Glioblastoma. Cancers (Basel). 2024;16: pubmed publisher |
Gauthier Coles G, Rahimi F, Br xf6 er A, Br xf6 er S. Inhibition of GCN2 Reveals Synergy with Cell-Cycle Regulation and Proteostasis. Metabolites. 2023;13: pubmed publisher |
Mirzaei R, Shafiee S, Vafaei R, Salehi M, Jalili N, Nazerian Z, et al. Production of novel recombinant anti-EpCAM antibody as targeted therapy for breast cancer. Int Immunopharmacol. 2023;122:110656 pubmed publisher |
Zhang Y, Zhang B, Lv C, Zhang N, Xing K, Wang Z, et al. Single-cell RNA sequencing identifies critical transcription factors of tumor cell invasion induced by hypoxia microenvironment in glioblastoma. Theranostics. 2023;13:3744-3760 pubmed publisher |
Abu Bakar N, Yeo Z, Hussin F, Madhavan P, Lim V, Jemon K, et al. Synergistic effects of combined cisplatin and Clinacanthus nutans extract on triple negative breast cancer cells. J Taibah Univ Med Sci. 2023;18:1220-1236 pubmed publisher |
Krishna S, Choudhury A, Keough M, Seo K, Ni L, Kakaizada S, et al. Glioblastoma remodelling of human neural circuits decreases survival. Nature. 2023;617:599-607 pubmed publisher |
Liu X, Hu Y, Xue Z, Zhang X, Liu X, Liu G, et al. Valtrate, an iridoid compound in Valeriana, elicits anti-glioblastoma activity through inhibition of the PDGFRA/MEK/ERK signaling pathway. J Transl Med. 2023;21:147 pubmed publisher |
Ishihara R, Oda T, Murakami Y, Matsumura I, Watanabe S, Asao Y, et al. Myeloma Microenvironmental TIMP1 Induces the Invasive Phenotype in Fibroblasts to Modulate Disease Progression. Int J Mol Sci. 2023;24: pubmed publisher |
Tocci P, Román C, Sestito R, Di Castro V, Sacconi A, Molineris I, et al. Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition. Cell Death Dis. 2023;14:5 pubmed publisher |
L xf3 pez Tejada A, Gri xf1 xe1 n Lis xf3 n C, Gonz xe1 lez Gonz xe1 lez A, Cara F, Luque R, Rosa Garrido C, et al. TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression. Int J Biol Sci. 2023;19:204-224 pubmed publisher |
Chua H, Chang M, Chen Y, Tsuei D, Jeng Y, Lee P, et al. PIM1-Induced Cytoplasmic Expression of RBMY Mediates Hepatocellular Carcinoma Metastasis. Cell Mol Gastroenterol Hepatol. 2023;15:121-152 pubmed publisher |
Dahabiyeh L, Hourani W, Darwish W, Hudaib F, Abu Irmaileh B, Deb P, et al. Molecular and metabolic alterations of 2,3-dihydroquinazolin-4(1H)-one derivatives in prostate cancer cell lines. Sci Rep. 2022;12:21599 pubmed publisher |
Rutecki S, Szulc P, Paku x142 a M, Uruski P, Radziemski A, Naumowicz E, et al. Pro-cancerogenic effects of spontaneous and drug-induced senescence of ovarian cancer cells in vitro and in vivo: a comparative analysis. J Ovarian Res. 2022;15:87 pubmed publisher |
Tian H, Liang Q, Shi Z, Zhao H. Exosomal CXCL14 Contributes to M2 Macrophage Polarization through NF-κB Signaling in Prostate Cancer. Oxid Med Cell Longev. 2022;2022:7616696 pubmed publisher |
Remy J, Linder B, Weirauch U, Day B, Stringer B, Herold Mende C, et al. STAT3 Enhances Sensitivity of Glioblastoma to Drug-Induced Autophagy-Dependent Cell Death. Cancers (Basel). 2022;14: pubmed publisher |
De Camargo M, Frazon T, Inacio K, Smiderle F, Amôr N, Dionísio T, et al. Ganoderma lucidum polysaccharides inhibit in vitro tumorigenesis, cancer stem cell properties and epithelial-mesenchymal transition in oral squamous cell carcinoma. J Ethnopharmacol. 2022;286:114891 pubmed publisher |
Cui S, Li F. RHPN1‑AS1 promotes ovarian carcinogenesis by sponging miR‑6884‑5p thus releasing TOP2A mRNA. Oncol Rep. 2021;46: pubmed publisher |
Li R, Tian T, Ge Q, He X, Shi C, Li J, et al. A phosphatidic acid-binding lncRNA SNHG9 facilitates LATS1 liquid-liquid phase separation to promote oncogenic YAP signaling. Cell Res. 2021;31:1088-1105 pubmed publisher |
Islam F, Gopalan V, Lu C, Pillai S, Lam A. Identification of novel mutations and functional impacts of EPAS1 in colorectal cancer. Cancer Med. 2021;10:5557-5573 pubmed publisher |
Ghosh S, Nataraj N, Noronha A, Patkar S, Sekar A, Mukherjee S, et al. PD-L1 recruits phospholipase C and enhances tumorigenicity of lung tumors harboring mutant forms of EGFR. Cell Rep. 2021;35:109181 pubmed publisher |
Park G, Choi S, Yoon Y, Kim D. TrkB/C-induced HOXC6 activation enhances the ADAM8-mediated metastasis of chemoresistant colon cancer cells. Mol Med Rep. 2021;23: pubmed publisher |
Masi I, Caprara V, Spadaro F, Chellini L, Sestito R, Zancla A, et al. Endothelin-1 drives invadopodia and interaction with mesothelial cells through ILK. Cell Rep. 2021;34:108800 pubmed publisher |
Zhao Z, Li Y, Liu H, Jain A, Patel P, Cheng K. Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer. Sci Adv. 2020;6:eabb0616 pubmed publisher |
Chi H, Tsai C, Wang C, Yang H, Lo C, Wang W, et al. DOCK6 promotes chemo- and radioresistance of gastric cancer by modulating WNT/β-catenin signaling and cancer stem cell traits. Oncogene. 2020;39:5933-5949 pubmed publisher |
Oh S, Yeom J, Cho H, Kim J, Yoon S, Kim H, et al. Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities. Nat Commun. 2020;11:3288 pubmed publisher |
Hyslop S, Alexander M, Thai A, Kersbergen A, Kueh A, Herold M, et al. Targeting platelets for improved outcome in KRAS-driven lung adenocarcinoma. Oncogene. 2020;39:5177-5186 pubmed publisher |
Xu J, Zhang Z, Qian M, Wang S, Qiu W, Chen Z, et al. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation. J Exp Clin Cancer Res. 2020;39:59 pubmed publisher |
Agarwal S, Chakravarthi B, Behring M, Kim H, Chandrashekar D, Gupta N, et al. PAICS, a Purine Nucleotide Metabolic Enzyme, is Involved in Tumor Growth and the Metastasis of Colorectal Cancer. Cancers (Basel). 2020;12: pubmed publisher |
Agarwal S, Behring M, Kim H, Bajpai P, Chakravarthi B, Gupta N, et al. Targeting P4HA1 with a Small Molecule Inhibitor in a Colorectal Cancer PDX Model. Transl Oncol. 2020;13:100754 pubmed publisher |
Chen Z, Zhang J, Xue H, Qian M, Guo X, Gao X, et al. Nitidine Chloride Is a Potential Alternative Therapy for Glioma Through Inducing Endoplasmic Reticulum Stress and Alleviating Epithelial-Mesenchymal Transition. Integr Cancer Ther. 2020;19:1534735419900927 pubmed publisher |
Wang S, Qi Y, Gao X, Qiu W, Liu Q, Guo X, et al. Hypoxia-induced lncRNA PDIA3P1 promotes mesenchymal transition via sponging of miR-124-3p in glioma. Cell Death Dis. 2020;11:168 pubmed publisher |
Ogawa K, Lin Q, Li L, Bai X, Chen X, Chen H, et al. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. J Hematol Oncol. 2019;12:144 pubmed publisher |
Lin Q, Chen X, Meng F, Ogawa K, Li M, Song R, et al. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis. Mol Cancer. 2019;18:156 pubmed publisher |
Palethorpe H, Smith E, Tomita Y, Nakhjavani M, Yool A, Price T, et al. Bacopasides I and II Act in Synergy to Inhibit the Growth, Migration and Invasion of Breast Cancer Cell Lines. Molecules. 2019;24: pubmed publisher |
Cagle P, Niture S, Srivastava A, Ramalinga M, Aqeel R, Ríos Colón L, et al. MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells. Sci Rep. 2019;9:9776 pubmed publisher |
Kim S, Shin R, Seo H, Kim M, Park J, Jeong S, et al. Identification of a Novel Fusion Gene, FAM174A-WWC1, in Early-Onset Colorectal Cancer: Establishment and Characterization of Four Human Cancer Cell Lines from Early-Onset Colorectal Cancers. Transl Oncol. 2019;12:1185-1195 pubmed publisher |
Akoury E, Ahangar P, Nour A, Lapointe J, Guérard K, Haglund L, et al. Low-dose zoledronate for the treatment of bone metastasis secondary to prostate cancer. Cancer Cell Int. 2019;19:28 pubmed publisher |
Kim A, Ma J. Isoliquiritin Apioside Suppresses in vitro Invasiveness and Angiogenesis of Cancer Cells and Endothelial Cells. Front Pharmacol. 2018;9:1455 pubmed publisher |
Chellini L, Caprara V, Spadaro F, Sestito R, Bagnato A, Rosanò L. Regulation of extracellular matrix degradation and metastatic spread by IQGAP1 through endothelin-1 receptor signalling in ovarian cancer. Matrix Biol. 2018;: pubmed publisher |
Xiao H, Bid H, Chen X, Wu X, Wei J, Bian Y, et al. Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy. PLoS ONE. 2017;12:e0180297 pubmed publisher |
Gill J, Connolly P, Roth M, Chung S, Zhang W, Piperdi S, et al. The effect of bone morphogenetic protein-2 on osteosarcoma metastasis. PLoS ONE. 2017;12:e0173322 pubmed publisher |
Lin A, Hu Q, Li C, Xing Z, Ma G, Wang C, et al. The LINK-A lncRNA interacts with PtdIns(3,4,5)P3 to hyperactivate AKT and confer resistance to AKT inhibitors. Nat Cell Biol. 2017;19:238-251 pubmed publisher |
Vazquez Rodriguez G, Abrahamsson A, Jensen L, Dabrosin C. Estradiol Promotes Breast Cancer Cell Migration via Recruitment and Activation of Neutrophils. Cancer Immunol Res. 2017;5:234-247 pubmed publisher |
Antony J, Tan T, Kelly Z, Low J, Choolani M, Recchi C, et al. The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer. Sci Signal. 2016;9:ra97 pubmed |
Kudinov A, Deneka A, Nikonova A, Beck T, Ahn Y, Liu X, et al. Musashi-2 (MSI2) supports TGF-? signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis. Proc Natl Acad Sci U S A. 2016;113:6955-60 pubmed publisher |
Kajiho H, Kajiho Y, Frittoli E, Confalonieri S, Bertalot G, Viale G, et al. RAB2A controls MT1-MMP endocytic and E-cadherin polarized Golgi trafficking to promote invasive breast cancer programs. EMBO Rep. 2016;17:1061-80 pubmed publisher |
Grossman M, Ben Chetrit N, Zhuravlev A, Afik R, Bassat E, Solomonov I, et al. Tumor Cell Invasion Can Be Blocked by Modulators of Collagen Fibril Alignment That Control Assembly of the Extracellular Matrix. Cancer Res. 2016;76:4249-58 pubmed publisher |
Busch B, Bley N, Müller S, Glaß M, Misiak D, Lederer M, et al. The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family. Nucleic Acids Res. 2016;44:3845-64 pubmed publisher |
Cho S, Kim Y, Sun H, Kim Y, Oh B, Yi K, et al. CXCL16 signaling mediated macrophage effects on tumor invasion of papillary thyroid carcinoma. Endocr Relat Cancer. 2016;23:113-24 pubmed publisher |
Estève P, Zhang G, Ponnaluri V, Deepti K, Chin H, Dai N, et al. Binding of 14-3-3 reader proteins to phosphorylated DNMT1 facilitates aberrant DNA methylation and gene expression. Nucleic Acids Res. 2016;44:1642-56 pubmed publisher |
Baldassarre T, Watt K, Truesdell P, Meens J, Schneider M, SenGupta S, et al. Endophilin A2 Promotes TNBC Cell Invasion and Tumor Metastasis. Mol Cancer Res. 2015;13:1044-55 pubmed publisher |
Midde K, Aznar N, Laederich M, Ma G, Kunkel M, Newton A, et al. Multimodular biosensors reveal a novel platform for activation of G proteins by growth factor receptors. Proc Natl Acad Sci U S A. 2015;112:E937-46 pubmed publisher |
Park G, Kim D, Kim Y, Kim S, Lee H, Yang J, et al. The Epstein-Barr virus causes epithelial-mesenchymal transition in human corneal epithelial cells via Syk/src and Akt/Erk signaling pathways. Invest Ophthalmol Vis Sci. 2014;55:1770-9 pubmed publisher |
